Will I resolve more complex problems?

Different practices. One analysis. Your solution.

Life Sciences

The Life Sciences Practice is composed of 30 specialists experienced in pharmaceutical and biotechnology law, food law, anti-monopoly law, healthcare and constitutional law.

We advise Polish and foreign entities in the pharmaceutical, healthcare, food and chemical sectors, and companies in the alcohol and tobacco industries.

We specialise in strategic advice in the areas of legislation, reimbursement, distribution, telemedicine solutions and compliance.

Our clients are local government authorities, which we advise on the restructuring of the healthcare system.

We cooperate with sector organisations in consultation over legislative bills, preparing, e.g. opinions on whether bills comply with the Constitution and international law; we also participate in drawing up such regulations.

Our awareness of market practice enables us to render advice that gives a high level of legal safety and that is also effective in business terms. Where legal risks are identified, we try to propose solutions that will not only mitigate these risks but also achieve goals as near as possible to the client’s original intentions.

We run a legal blog where we regularly comment on legal changes affecting our clients' activity.

related articles

1st Kenya - Poland e-Health Summit

News | 21.03.2018 On March 20-21, we invite you to Nairobi, Kenya, to the first ever and only event of this type this year - 1st Kenya - Poland eHealth Summit! DZP will be represented by Piotr Najbuk.

full story

Chambers Europe 2018 distinction for DZP

News | 12.03.2018 We are very pleased to announce that both our law firm and our experts have once again been recommended in the Chambers Europe 2018 ranking that was published last week.

full story

Dolnośląskie Oncology Centre obtains ISO 37001:2016

Deals corner | 11.10.2017 We advised the Oncology Centre in Wrocław on implementing the new ISO 37001:2016 standard. It's the first hospital and one of the first entities in Poland to decide to implement the new standard.

full story

Medicinal product regulation and product liability in Poland

Publication | 01.07.2017 The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability.

full story

Pharmaceutical IP and competition law in Poland: overview

Publication | 01.07.2017 The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.

full story

DZP expands Food Law Team within Life Sciences Practice

News | 08.05.2017 DZP’s Food Law Team has been enhanced by Monika Zagrajek, specialist in food law with special focus on dietary supplements, fortified foods and foods for particular uses.

full story

Chambers Europe: 24 experts in 15 specialisations

News | 10.04.2017 An expanded, i.e. European, part of the Chambers and Partners ranking has just been published. The Europe Guide is a supplement to the Global Guide, and also distinguishes DZP and its experts.

full story

DZP distinguished in 5 categories in Ranking of Regulatory Law Firms

News | 24.03.2017 Yesterday evening Polityka Insight announced the results of its second Ranking of Regulatory Law Firms. We are pleased to inform you that DZP has been distinguished in 5 out of 6 categories.

full story

NAC upholds decision on anti-pneumococcal vaccination

Deals corner | 30.01.2017 On 13 December the NAC dismissed PGF Urtica's appeal against the tender result for the anti-pneumococcal vaccines announced by the Public Procurement Department at the Ministry of Health.

full story

Distribution and marketing of drugs in Poland: overview

Publication | 01.11.2016 Overview of distribution and marketing of drugs law (pre-conditions for distribution, licensing, wholesale distribution, marketing to consumers and professionals and engagement with patient organisations).

full story

Commercialisation of healthcare in Poland: overview

Publication | 01.11.2016 Overview of the regulatory framework for the commercialisation of medical products in Poland (requirements for drugs, medical devices, biological products and natural health products).

full story

Support for medical start-ups – DZP to cooperate with Microsoft

News | 21.10.2016 On 20 October 2016 our Law Firm signed an agreement with Microsoft. Our cooperation is aimed at providing full-range support to start-ups in the healthcare sector.

full story

DZP succeeds in overturning SAC case law unfavourable for patients

News | 06.10.2016 On 5 October 2016 the Supreme Administrative Court (SAC) passed a judgment that followed a pro-constitutional interpretation, favourable for patients, of the Reimbursement Act, overturning current SAC case law in cases of this type.

full story

Tomasz Zalasiński to be co-chairman of Healthcare Experts Committee

News | 05.10.2016 The Human Rights Ombudsman has set up a Healthcare Experts Committee and has invited doctors and specialists involved in the functioning of the healthcare system to participate. Dr Tomasz Zalasiński has been appointed co-chairman of the Committee.

full story

USP Zdrowie buys Polish-Swedish Naturell Group

Deals corner | 18.07.2016 USP Zdrowie Group acquired 100% of shares in the Polish-Swedish Naturell Group. We were the main adviser and co-ordinated the Polish-Swedish team of lawyers and tax and financial advisers.

full story

Michał Czarnuch and Tomasz Kaczyński are new partners in DZP

News | 01.07.2016 Michał Czarnuch and Tomasz Kaczyński, who have been associated with the Life Sciences Practice for years now, have become partners in DZP as of 1 July.

full story

Chambers Europe recommends DZP and its experts in 16 specialisations

News | 26.04.2016 An expanded, i.e. European, part of the Chambers and Partners ranking has just been published. The Europe Guide is a supplement to the Global Guide results published in March and also distinguishes DZP and its experts again.

full story

DZP wins battle over innovative treatment for patients

News | 15.02.2016 The judgment passed by the VAC in Warsaw could lead to a change favourable for patients in how reimbursement regulations are interpreted. VAC upheld the position we put forward in the appeal against the Minister of Health’s decision.

full story

DZP distinguished in Ist Ranking of Regulatory Law Firms 2016

News | 29.01.2016 28 January 2016 Polityka Insight announced the results of its first Ranking of Regulatory Law Firms 2016. Our law firm has been distinguished in three out of five categories: Pharmaceutical, Banking, Energy.

full story

Food Supplements: Trading More Effectively Throughout The EU

Event | 27.10.2015 On 27 October in Brussels the European Federation of Associations of Health Product Manufacturers (EHPM) is holding workshops on Food Supplements during which experts from DZP’s Life Sciences Practice are to speak.

full story

Pharmaceutical company owners merged with FMCG market leader

Deals corner | 23.10.2015 Maspex Wadowice Group purchased shares in Sequoia sp. z o.o. from a minority shareholder, Sorabot investment fund. Our Law Firm acted for the Sequoia majority shareholders.

full story

Michał Tracz elected for a Chairman of Polish Council for Supplements and Nutritional Foods Ethics Commission

News | 14.08.2015 In June, we announced that Michał Tracz had been appointed to the Ethics Committee of the Polish Council for Supplements and Nutritional Foods (KRSiO). Today, we announce that he has been elected its Chairman.

full story

Largest transaction on healthcare market made with our support

Deals corner | 23.07.2015 We have advised Mr Maciej Sadowski, founder and owner of Magodent sp. z o.o. , which runs two hospitals, upon the sale of eighty percent of shares to LUX MED Group.

full story

Michał Tracz on Polish Council for Supplements and Nutritional Foods Ethics Commission

News | 01.06.2015 We are pleased to inform you that Michał Tracz, Associate with our Life Sciences Practice, has been appointed as a member of the Ethics Commission of the Polish Council for Supplements and Nutritional Foods.

full story

DZP coordinates three-part transaction with GSK and Novartis

Deals corner | 26.05.2015 DZP advised GlaxoSmithKline in a three-part conditional transaction with Novartis AG in the following areas: health care means (Consumer Healthcare), vaccinations and cancer medicines.

full story

DZP report on oncology and queuing packages

Deals corner | 02.04.2015 On February saw the publication of a regulatory report drawn up by a team led by Marcin Matczak, Tomasz Zalasiński and Michał Czarnuch on the request of the Supreme Medical Chamber.

full story

Chambers Europe recommends DZP and its experts

News | 25.04.2014 Yestarday the European edition of Chambers & Partners was published. We are pleased to inform you that both our law firm and DZP’s experts have again been recommended in the following categories:

full story

DZP - member of Polish Council for Supplements and Nutritional Foods

News | 10.03.2014 We are pleased to inform you that our law firm has become a supporting member of the Polish Council for Supplements and Nutritional Foods. DZP will be represented at the Association by Tomasz Kaczyński.

full story

Additional health insurance would strengthen public system

News | 26.11.2013 A conference was held on 26 November together with an experts' debate on "Additional health insurance 2013". Additional health insurance would strengthen the public healthcare system, said experts, one of whom was Marcin Matczak.

full story

English translation of the Pharmaceutical Law available in bookshops

News | 28.10.2013 We are pleased to announce that an English version of the Pharamaceutical Law and the Act on the Reimbursement of Medicines, Foodstuffs Intended for Particular Nutritional Uses and Medical Devises is now available in bookshops.

full story

Private health insurance report

Publication | 15.04.2013 Poland is on the verge of an important breakthrough. Over the next 20 years, we need to reform the healthcare system, making it ready to pick up demographic, economic and technological challenges of the future.

full story

Commercialisation of Healthcare (Poland)

Publication | 15.03.2013 Overview of the regulatory framework for the commercialisation of medical products in Poland (requirements for drugs, medical devices, biological products and natural health products).

full story

New regulations will aff ect the relationship between manufacturers and distributors of cosmetic products

Publication | 13.03.2013 There are less than six months until the introduction of several new legal requirements for both manufacturers and distributors of cosmetic products.

full story

Marcin Matczak joins the team of INFARMA Disciplinary Court

News | 16.11.2012 We are pleased to announce that on 16 November Marcin Matczak was registered by the Board of the INFARMA Employers' Union of Innovative Pharmaceutical Companies as an expert to the Disciplinary Court.

full story

DZP – once again out in front in Rzeczpospolita ranking

News | 11.05.2010 It is our great pleasure to inform you that our Law Firm has for the eighth time in a row taken first place in the leading ranking of law firms published in the Rzeczpospolita newspaper on 11 May.

full story